
Reprogramming molecules are getting dosed into patients for the first time, with the goal of restoring function lost due to aging. I‘ve had over 30 recorded conversations about the longevity space and didn’t realize this is happening so soon!We sat down with Dr. Jamie Justice, the geroscientist running the $101M XPRIZE Healthspan competition, and she told us there are five teams pursuing reprogramming, and hundreds pursuing other approaches. The $101M prize is to be awarded to teams that can restore muscle, cognitive, and immune function by 10 to 20 years.We discussed how the longevity field has a serious hype problem. We‘ve found hundreds of interventions that can extend lifespan in model organisms (reprogramming among them) and yet none have been translated into humans.The XPRIZE is changing that, by challenging the field to get out of the lab and into the clinic. $101M for those that can show results now, not in a decade, is a huge incentive to turn the hype into reality.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

How DARPA prepares for AI-designed bioweapons & is accelerating progress towards longevity biotech - Dr. Mike Koeris, DARPA Director

Replacement & Biostasis: radical approaches for solving aging - Kris Borer, Author & Investor

Selecting the Superman? Embyro selection with Jonathan Anomaly

The future of AI-powered personalized drugs is only a few years away - Latent Labs founder Simon Kohl
Free AI-powered recaps of Free Radicals and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.